ID: ALA5069783

Max Phase: Preclinical

Molecular Formula: C29H38N4O3

Molecular Weight: 490.65

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1cnc2c(c1)CN(C(=O)[C@H]1CC[C@H](OC(C)C)CC1)c1cc(N3CC4CCC3CO4)ccc1N2

Standard InChI:  InChI=1S/C29H38N4O3/c1-18(2)36-24-8-4-20(5-9-24)29(34)33-15-21-12-19(3)14-30-28(21)31-26-11-7-22(13-27(26)33)32-16-25-10-6-23(32)17-35-25/h7,11-14,18,20,23-25H,4-6,8-10,15-17H2,1-3H3,(H,30,31)/t20-,23?,24-,25?

Standard InChI Key:  IMTQUGOIFSTEJD-FAYYJSRZSA-N

Associated Targets(Human)

Isocitrate dehydrogenase [NADP] cytoplasmic 40980 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MOG-G-UVW 38 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

P-glycoprotein 1 14716 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 490.65Molecular Weight (Monoisotopic): 490.2944AlogP: 5.33#Rotatable Bonds: 4
Polar Surface Area: 66.93Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.89CX Basic pKa: 6.14CX LogP: 4.71CX LogD: 4.69
Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.62Np Likeness Score: -0.23

References

1. Huang C, Fischer C, Machacek MR, Bogen S, Biftu T, Huang X, Reutershan MH, Otte R, Hong Q, Wu Z, Yu Y, Park M, Chen L, Biju P, Knemeyer I, Lu P, Kochansky CJ, Hicks MB, Liu Y, Helmy R, Fradera X, Donofrio A, Close J, Maddess ML, White C, Sloman DL, Sciammetta N, Lu J, Gibeau C, Simov V, Zhang H, Fuller P, Witter D..  (2022)  Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 Inhibitors.,  13  (4.0): [PMID:35450359] [10.1021/acsmedchemlett.2c00089]

Source